» Articles » PMID: 30654057

Preclinical Studies of Ropivacaine Extended-release from a Temperature Responsive Hydrogel for Prolonged Relief of Pain at the Surgical Wound

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2019 Jan 18
PMID 30654057
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Postoperative pain is a common form of acute pain that has been treated commonly by local anesthetics through regional nerve blocking. In this study, a series of experiments were conducted using rats to investigate the pharmacokinetic, distribution, and efficacy of a temperature responsive hydrogel-based drug delivery device (PF-72) containing ropivacaine (0.75%) for extended relief of postoperative pain by allowing the prolonged release of ropivacaine. When the ropivacaine was administered using PF-72, its concentration-time curve (AUC) and peak concentration (C) were 577.0 h*ng/mL and 271.9 ng/mL, respectively. In contrast when the ropivacaine solution was administered using saline solution, its AUC and C were 982.8 h*ng/mL and 423.6 ng/mL, respectively. In the tissue distribution study, the peak concentration and mean area under the curve of the ropivacaine in injection area (target tissue) were found about 2-fold higher in the case of PF-72 compared with the case of conventional ropivacaine solution. These results clearly demonstrate the capability of PF-72 hydrogel to retain the ropivacaine at the injection site for an extended period. Effective extended (at least 24 h) pain relief of ropivacaine administered using PF-72 was found in the pharmacodynamic study of prolonged analgesic effect. The results of this study indicated that local drug delivery by PF-72 hydrogel formulation may be an effective method to achieve extended relief of pain. Other advantages of ropivacaine administration using PF-72 include reduced systemic side effects and high localization of a drug in target tissues.

Citing Articles

An Injectable Oil-Based Depot Formulation of -Acyloxymethyl Prodrug of Ropivacaine for Long-Acting Local Analgesia: Formulation Development and In Vitro/In Vivo Evaluation.

Liu X, Zhao R, Xu P, Qian J, Zhang P, Xie X Pharmaceutics. 2025; 17(1).

PMID: 39861687 PMC: 11768344. DOI: 10.3390/pharmaceutics17010037.


Comparative Analysis of Temperature-Responsive Hydrogel (PF 72) for Postoperative Pain After Bimaxillary Surgery: A Retro-spective Study.

Yun C, Kim K, Lee W, Kim S Aesthetic Plast Surg. 2024; 48(7):1271-1275.

PMID: 38326500 DOI: 10.1007/s00266-023-03846-6.


Transumbilical Silicone Breast Augmentation: A 13-Year Experience and 5-Year Analysis.

Lee W, Kim S Aesthetic Plast Surg. 2024; 48(18):3627-3636.

PMID: 38326499 DOI: 10.1007/s00266-024-03850-4.


Effectiveness of a Novel Temperature-Responsive Hydrogel (PF72) for Postoperative Pain Relief in Breast Augmentation.

Cho J, Kim K, Lee W, Young Go J, Kim S J Clin Med. 2024; 13(1).

PMID: 38202117 PMC: 10779951. DOI: 10.3390/jcm13010110.


Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple Therapeutics.

Xu Y, Dong X, Xu H, Jiao P, Zhao L, Su G Pharmaceutics. 2023; 15(9).

PMID: 37765278 PMC: 10537372. DOI: 10.3390/pharmaceutics15092309.